Contact Email: ramachandran.arudchandran@nih.gov
Monday, March 28, 2022 | 2:00 PM EST
The HEAL Biomarker Program is dedicated to advancing biomarkers for pain conditions. The program is focused on supporting research to promote biomarkers that will improve the quality and efficiency of Phase II clinical trials and clinical practice. The HEAL Biomarker Program provides support for biomarker and endpoint discovery, along with analytical and clinical validation in a manner that is consistent with FDA guidelines.
An interactive Q&A webinar will be held for interested applicants on Monday, March 28, 2022, at 2:00 PM ET. All investigators interested in learning about the HEAL Biomarker funding opportunities are encouraged to participate. Investigators can find information about the current open funding opportunity at:
RFA-NS-22-050: HEAL Initiative: Discovery of Biomarkers and Biomarker Signatures to Facilitate Clinical Trials for Pain Therapeutics (UG3/UH3 Clinical Trial Optional) (nih.gov)
Receipt dates for this HEAL Biomarker Funding Opportunity are March 11, 2022, June 23, 2022, and October 13, 2022.